Skip to main content
PharmaBlock Sciences (Nanjing), Inc. logo

PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings

Ticker · 300725 ISIN · CNE1000035K5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,618 across all filing types
Latest filing 2025-04-30 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300725

About PharmaBlock Sciences (Nanjing), Inc.

https://www.pharmablock.com

PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.

Recent filings

Filing Released Lang Actions
第四届董事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Nanjing Yaoshi Technology Co., Ltd. It details the approval of the 2024 Environmental, Social and Governance (ESG) report by the board. The document is short (658 characters) and primarily announces the board's decision rather than containing the full ESG report itself. It references the ESG report and states that details are disclosed on an external website. This fits the category of a Board/Management Information announcement, as it concerns board meeting resolutions and approvals. It is not the full ESG report (which would be classified as SR), nor is it a report publication announcement since it does not announce the publication of a report but rather the board's resolution. Therefore, the correct classification is MANG (Board/Management Information).
2025-04-30 Chinese
关于召开公司2024年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2024 Annual General Meeting (AGM) of 南京药石科技股份有限公司, including the date, time, location, voting procedures (both in-person and online), agenda items to be voted on, and instructions for shareholders to register and participate. It includes the agenda proposals such as the 2024 annual report, financial statements, board reports, remuneration, profit distribution, and other corporate governance matters. The document is not the actual annual report or financial statements but a formal notification to shareholders about the upcoming AGM and how to participate. It also includes attachments like proxy forms and registration forms. The document length is about 5786 characters, which is consistent with a detailed AGM notice. Therefore, this document fits the category of AGM Information (AGM-R).
2025-04-24 Chinese
关于2024年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2024 annual profit distribution plan of the company, including details about the proposed cash dividend, board and supervisory committee approvals, and related financial figures. It does not contain the full annual report or detailed financial statements but rather focuses on the profit distribution proposal to be approved at the upcoming shareholders' meeting. The document length is under 5,000 characters and it is a formal announcement of a profit distribution plan, which aligns with a Notice of Dividend Amount filing rather than a full Annual Report or Management Report. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2025-04-24 Chinese
关于2025年度对合并报表范围内子公司提供担保额度预计的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's expected guarantee limit for subsidiaries within the consolidated financial statements for the year 2025. It includes details about the guarantee amount, the board and supervisory committee's approval, and the need for shareholder meeting approval. The document does not contain actual financial statements or detailed financial analysis but rather a corporate announcement about a financial guarantee authorization. It is not a full financial report, audit report, or earnings release. The document is a regulatory announcement about a capital guarantee limit and related board decisions, fitting best under the category of Capital/Financing Update (CAP). The document length is under 5,000 characters and contains substantive content about financing guarantees, not just a report publication announcement or a simple notification. Therefore, the classification is CAP with high confidence.
2025-04-24 Chinese
华泰联合证券有限责任公司关于南京药石科技股份有限公司2024年度内部控制自我评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an internal control self-evaluation report for the year 2024 of Nanjing PharmaBlock Technology Co., Ltd., with verification opinions from Huatai United Securities Co., Ltd., the sponsoring institution. It discusses the internal control evaluation scope, procedures, findings, and conclusions, including references to audit opinions from a certified public accounting firm. The document is detailed, over 11,000 characters, and contains substantive content about internal control systems, risk assessments, and audit results. It is not a full annual report or earnings release but a specialized report focused on internal control and audit verification. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. The document is not merely an announcement or certification but contains detailed evaluation and audit content. Therefore, the appropriate classification is AR with high confidence.
2025-04-24 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the fourth meeting of the fourth board of directors of Nanjing Yaoshi Technology Co., Ltd. It includes approvals of various reports such as the 2024 annual general manager work report, 2024 annual board work report, 2024 annual report and summary, 2024 financial final report, 2024 audit report, and other related financial and governance reports. The document also mentions that these reports will be submitted to the shareholders' meeting for approval and that the full reports are available on the official disclosure website (cninfo.com.cn). The document itself does not contain the full annual report or financial statements but is a formal board meeting resolution announcement regarding these reports and other corporate governance matters. This fits the category of Board/Management Information (MANG) as it announces board meeting decisions and management reports approvals, rather than the reports themselves or their publication announcements. The document length (7315 characters) and content confirm it is not a brief publication announcement or a full annual report. Therefore, the appropriate classification is MANG with high confidence.
2025-04-24 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.